Loading…

Cross-sectional evaluation of the saccharin transit time test for primary ciliary dyskinesia: did we discard this tool too soon?

Primary ciliary dyskinesia (PCD) is a rare and heterogeneous disease that is difficult to diagnose and requires complex and expensive diagnostic tools. The saccharin transit time test is a simple and inexpensive tool that may assist in screening patients with PCD. This study aimed to compare changes...

Full description

Saved in:
Bibliographic Details
Published in:São Paulo medical journal 2023, Vol.141 (6), p.e2022508-e2022508
Main Authors: Toro, Mariana Dalbo Contrera, Ortiz, Erica, Marson, Fernando Augusto Lima, Pinheiro, Laíza Mohana, Toro, Adyléia Aparecida Dalbo Contrera, Ribeiro, José Dirceu, Sakano, Eulália
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Primary ciliary dyskinesia (PCD) is a rare and heterogeneous disease that is difficult to diagnose and requires complex and expensive diagnostic tools. The saccharin transit time test is a simple and inexpensive tool that may assist in screening patients with PCD. This study aimed to compare changes in the electron microscopy findings with clinical variables and saccharin tests in individuals diagnosed with clinical PCD (cPCD) and a control group. An observational cross-sectional study was conducted in an otorhinolaryngology outpatient clinic from August 2012 to April 2021. Patients with cPCD underwent clinical screening questionnaires, nasal endoscopy, the saccharin transit time test, and nasal biopsy for transmission electron microscopy. Thirty-four patients with cPCD were evaluated. The most prevalent clinical comorbidities in the cPCD group were recurrent pneumonia, bronchiectasis, and chronic rhinosinusitis. Electron microscopy confirmed the clinical diagnosis of PCD in 16 of the 34 (47.1%) patients. The saccharin test could assist in screening patients with PCD due to its association with clinical alterations related to PCD.
ISSN:1516-3180
1806-9460
1806-9460
DOI:10.1590/1516-3180.2022.0508.R2.13032023